Fact Sheet 412
Zalcitabine (Hivid, ddC)
ddC (Hivid) was a drug used for antiretroviral therapy (ART). It was manufactured by Roche. ddC was also known as zalcitabine or dideoxycytidine. ddC was a nucleoside analog reverse transcriptase inhibitor, or nuke. ddC was associated with significant risk of serious side effects, including peripheral neuropathy.
ddC was approved in 1992 as an antiretroviral drug (ARV) for people with HIV infection. The manufacture and distribution of ddC (Hivid) was discontinued by the manufacturer as of December 31, 2006.
Back to Fact Sheet Categories
The AIDS InfoNet is a project of the International Association of Providers of
Partially funded by the National Library of Medicine